<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01342835</url>
  </required_header>
  <id_info>
    <org_study_id>UCCK-55</org_study_id>
    <secondary_id>RAA12</secondary_id>
    <nct_id>NCT01342835</nct_id>
  </id_info>
  <brief_title>Postoperative Analgesia in Children After Propofol Anesthesia</brief_title>
  <acronym>propan</acronym>
  <official_title>Postoperative Analgesia in Children After Propofol Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Clinical Centre of Kosova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Clinical Centre of Kosova</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that patients anesthetized with sevoflurane have more pain,
      postoperatively, than those anesthetized with propofol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a randomize, prospective, double-blind study, the subjects are 100 premedicated children,
      aged 3 to 6 years, who undergo one type of surgical procedure, hernia repair surgery.
      Anesthesia is maintains with propofol anesthesia (group P, n=50) or with sevoflurane
      anesthesia (group S, n=50). and fentanyl administered during surgery. Faces Pain Scale (FPS)
      is use to assess pain severity.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">July 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>120 minutes</time_frame>
    <description>The Faces Pain Scale (FPS) (from five face drawings: 0 = no pain, 5 = extreme pain) is used to assess pain severity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>recovery time</measure>
    <time_frame>120 minutes</time_frame>
    <description>Recovery time, defined as the time until eye opening on command or the time of first response to command after anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse effects</measure>
    <time_frame>0-120 minutes</time_frame>
    <description>Adverse effects during the surgery and after recovery: hypotension, bradicardia, intense coughing, hypersalivation and laryngospasm, nausea, and vomiting.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>drug: propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug:Propofol and sevoflurane The induction dose of propofol is 3-5 mg/kg-1 (mean induction dose: 4 mg/kg-1) follow by propofol infusion (12 mg/kg/h-1 for the first 10 min of general anesthesia, 9 mg/kg/h-1 for another 10 min, and 6 mg/kg/h-1 thereafter; mean maintenance dose: 9 mg/kg/h-1) and a 50:50 mixture of N2O and O2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevoflurane group:sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug:Sevoflurane and Propofol Mask induction is perform with sevoflurane (4-6%) follow by 1.5-2% sevoflurane in a 50:50 mixture of N2O and O2.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>The induction dose of propofol is 3-5 mg/kg-1 (mean induction dose: 4 mg/kg-1) follow by propofol infusion (12 mg/kg/h-1 for the first 10 min of general anesthesia, 9 mg/kg/h-1 for another 10 min, and 6 mg/kg/h-1 thereafter; mean maintenance dose: 9 mg/kg/h-1) and a 50:50 mixture of N2O and O2.</description>
    <arm_group_label>drug: propofol</arm_group_label>
    <arm_group_label>Sevoflurane group:sevoflurane</arm_group_label>
    <other_name>Diprivan</other_name>
    <other_name>Sevorane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is 3- 6 years old

          -  Patient is scheduled for hernia repair surgery at University Clinical center of Kosovo
             Patients is ASA I/II Patient meets criteria to receive either propofol or sevoflurane
             anesthesia Patient's parent/guardian provides written consent

        Exclusion Criteria:

          -  allergy to any of the drugs

          -  preoperative anxiety

          -  postoperative agitation

          -  ASA physical status &gt;II
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antigona Hasani, MD,MSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Clinical Centre of Kosova</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antigona Hasani, MD, MSC</last_name>
    <phone>+37744402781</phone>
    <email>antigona.hasani@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antiogna Hasani</last_name>
    <phone>+38138500600</phone>
    <phone_ext>3015</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Clinical Center of Kosovo</name>
      <address>
        <city>Pristina</city>
        <state>Kosovo</state>
        <zip>10000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antigona Hasani, MD,MSC</last_name>
      <phone>+38138500600</phone>
      <phone_ext>3015</phone_ext>
      <email>antigona.hasani@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2011</study_first_submitted>
  <study_first_submitted_qc>April 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2011</study_first_posted>
  <last_update_submitted>April 26, 2011</last_update_submitted>
  <last_update_submitted_qc>April 26, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 27, 2011</last_update_posted>
  <responsible_party>
    <name_title>Antigona Hasani</name_title>
    <organization>UCCK</organization>
  </responsible_party>
  <keyword>propofol</keyword>
  <keyword>sevoflurane</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

